2m 2m 2m 2m 2m 2m 2m
ACTUATE THERAP (ACTU)
NASDAQ
$1.63+$0.13 (+8.67%)
Price as of Jul 14, 2026 10:12 AM EDT- $35.9MMarket Cap
- -75.81%1-Year Change
- BiotechnologyIndustry
ACTUATE THERAP (ACTU)
$1.63+$0.13 (+8.67%)
ACTU | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.50 | ||
Change | +$0.29 (+23.97%) | ||
Open | $1.25 | ||
High | $1.60 | ||
Low | $1.25 | ||
Previous Close | $1.21 | ||
Volume | 2,686,663 | ||
30-Day Average Volume | 328,296 | ||
1-Week Change | 7.14% | ||
1-Month Change | -25.74% | ||
1-Year Change | -75.81% | ||
3-Year Change | -70.00% | ||
5-Year Change | -70.00% | ||
Fundamentals | |||
Shares Outstanding | 23.9M | ||
Total Assets | $8.9M | ||
Market Cap | $35.9M | ||
Enterprise Value | $27.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$5.0M | ||
EBIT | $0.00 | ||
EBITDA | $0.00 | ||
Net Working Capital | $3.8M | ||
EPS | -$0.24 | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | 9 | ||
P/E | -6 | ||
PEG | N/A | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue